Equities

Owens & Minor Inc

Owens & Minor Inc

Actions
Health CareMedical Equipment and Services
  • Price (USD)16.04
  • Today's Change0.23 / 1.45%
  • Shares traded3.00
  • 1 Year change-0.12%
  • Beta0.3871
Data delayed at least 15 minutes, as of Sep 20 2024 00:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in USDIncome statement in USDView more

Year on year Owens & Minor Inc had net income fall from a gain of 22.39m to a loss of 41.30m despite a 3.80% increase in revenues from 9.96bn to 10.33bn. An increase in the selling, general and administrative costs as a percentage of sales from 16.38% to 17.23% was a component in the falling net income despite rising revenues.
Gross margin20.78%
Net profit margin-0.40%
Operating margin1.11%
Return on assets-0.80%
Return on equity-4.83%
Return on investment-1.25%
More ▼

Cash flow in USDView more

In 2023, Owens & Minor Inc increased its cash reserves by 216.67%, or 186.74m. The company earned 740.71m from its operations for a Cash Flow Margin of 7.17%. In addition the company used 137.25m on investing activities and also paid 417.33m in financing cash flows.
Cash flow per share3.14
Price/Cash flow per share5.15
Book value per share11.17
Tangible book value per share-14.28
More ▼

Balance sheet in USDView more

Owens & Minor Inc has a Debt to Total Capital ratio of 70.76%, a lower figure than the previous year's 257.73%.
Current ratio1.09
Quick ratio0.5141
Total debt/total equity2.42
Total debt/total capital0.7076
More ▼

Growth rates in USD

Year on year, growth in earnings per share excluding extraordinary items dropped -285.53%.
Div yield(5 year avg)0.05%
Div growth rate (5 year)--
Payout ratio (TTM)--
EPS growth(5 years)--
EPS (TTM) vs
TTM 1 year ago
57.72
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.